Leveraging Peripheral CB1 Antagonism in 1,4,5,6-Tetrahydropyridazine-Based Amidine Substituted Sulfonyl Analogs for Treating Metabolic Disorders
用户6X7Ch8WUQ_gI
1个月前
63
10
已完结
1. 系统已在2025-10-20 09:12:37对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: https://doi.org/10.1021/acs.jmedchem.5c01158
文献链接: https://pubs.acs.org/doi/10.1021/acs.jmedchem.5c01158
其他信息:
出版社: American Chemical Society (ACS)
作者: Pinaki Bhattacharjee; Szabolcs Dvorácskó; Paul Volesky; Océane Pointeau; Nicholas Rutland; Luca Maccioni; Grzegorz Godlewski; Tony Jourdan; Sergio A. Hassan; Resat Cinar; Malliga R. Iyer
全文下载地址: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5c01158
